Interestingly, we additionally found that HSPB6 expression in castration-resistant prostate cancer (CRPCs) and neuroendocrine prostate cancer (NEPCs) was lower than in primary prostate cancer (Fig. 2J). This evidence concerns the gene HSPB6 and prostate carcinoma.